Temporal lobe epilepsy (TLE) is a prevalent, often drug resistant form of acquired epilepsy that frequently presents with co-morbidities such as cognitive dysfunction. Oxidative stress has been implicated in various neurological diseases including experimental models of TLE. However, whether oxidative stress contributes to chronic seizures and/or cognitive decline in TLE is unknown. Isoketals (IsoKs) and neuroketals (NeuroKs) are highly reactive gamma-ketoaldehydes (?KAs) formed via the non-enzymatic, free radical catalyzed, peroxidation of arachidonic acid and docosahexaenoic acid, respectively which are highly enriched in brain. ?KAs rapidly and irreversibly adduct to lysine residues and readily crosslink proteins which can lead to cell dysfunction. Elevated IsoKs in plasma and tissues occur in pathological conditions including Alzheimer's disease, atherosclerosis, and inflammation. Pharmacological scavenging of ?KAs has been shown to markedly inhibit cognitive impairment in humanized apoE4 mice, an animal model of Alzheimer's disease. The goals of this project are to 1) determine whether IsoK and/or NeuroK adduct formation occurs during epileptogenesis, 2) Identify candidate hippocampal proteins adducted by IsoKs/NeuroKs using mass spectrometry during epileptogenesis, 3) determine if a pharmacological scavenger of ?KAs, salicylamine (SA) can inhibit cognitive decline and/or chronic seizures associated with epileptogenesis and 4) determine if SA can inhibit neuronal death and/or reactive gliosis associated with epileptogenesis. Collectively, this project can identify a novel role of ?KAs as mediators of oxidative stress in chronic epilepsy and/or cognitive impairment associated with TLE and provides a therapeutic approach for its treatment.
If successful, the studies proposed herein have the potential to elucidate a novel mechanism of acquired epilepsy and associated cognitive dysfunction. The proposal can provide a therapeutic avenue to prevent learning and memory deficits associated with the epilepsies. Additionally, studies will determine if the therapeutic is antiepileptogenic and/or neuroprotective.
|Pearson-Smith, Jennifer N; Liang, Li-Ping; Rowley, Shane D et al. (2017) Oxidative Stress Contributes to Status Epilepticus Associated Mortality. Neurochem Res 42:2024-2032|
|Pearson-Smith, Jennifer N; Patel, Manisha (2017) Metabolic Dysfunction and Oxidative Stress in Epilepsy. Int J Mol Sci 18:|
|McElroy, Pallavi B; Liang, Li-Ping; Day, Brian J et al. (2017) Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation. Exp Neurol 298:13-22|
|McElroy, Pallavi B; Sri Hari, Ashwini; Day, Brian J et al. (2017) Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol: A NOVEL MECHANISM OF INHIBITING NEUROINFLAMMATION IN VITRO. J Biol Chem 292:5532-5545|
|Heischmann, Svenja; Quinn, Kevin; Cruickshank-Quinn, Charmion et al. (2016) Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis. Sci Rep 6:31424|
|Pearson, Jennifer N; Patel, Manisha (2016) The role of oxidative stress in organophosphate and nerve agent toxicity. Ann N Y Acad Sci 1378:17-24|
|Walker, Lauren E; Janigro, Damir; Heinemann, Uwe et al. (2016) WONOEP appraisal: Molecular and cellular biomarkers for epilepsy. Epilepsia 57:1354-62|
|Liang, Li-Ping; Patel, Manisha (2016) Plasma cysteine/cystine redox couple disruption in animal models of temporal lobe epilepsy. Redox Biol 9:45-49|
|Patel, Manisha (2016) Targeting Oxidative Stress in Central Nervous System Disorders. Trends Pharmacol Sci 37:768-78|
|Grone, Brian P; Marchese, Maria; Hamling, Kyla R et al. (2016) Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish. PLoS One 11:e0151148|
Showing the most recent 10 out of 18 publications